Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine

Table 2 Relevant laboratory values

From: Impact of COPD on clinical and CT characteristics of COVID-19-associated pneumonia: single tertiary center experience

Data

COPD (n = 50)

Non-COPD (n = 231)

p value

WBC, × 109/L

7.73 ± 4.94

6.33 ± 3.6

0.064

ALC, × 109/L

1.19 ± 0.63

1.33 ± 0.99

0.343

ANC, × 109/L

6.06 ± 4.68

4.54 ± 3.22

0.033*

NLR

6.46 ± 6.41

4.34 ± 3.98

0.029*

ALT, U/L

36.13 ± 26.06

39.2 ± 36.74

0.575

AST, U/L

36.56 ± 22.27

39.67 ± 27.81

0.461

Total protein, g/L

66.99 ± 5.75

67.57 ± 7.33

0.597

Prothrombin time, s

14.71 ± 2.71

13.9 ± 4.57

0.253

Fibrinogen, g/L

4.61 ± 2.18

4.19 ± 1.79

0.208

  1. ALC—absolute lymphocyte count; ALT—alanine aminotransferase; ANC—absolute neutrophil count; AST—aspartate aminotransferase; COPD—chronic obstructive pulmonary disease; NLR—neutrophil/lymphocyte ratio; WBC—white blood cells 
  2. * Statistically significant p < 0.05
Back to article page